Proportion of bloodstream infection due to Escherichia coli resistant in United Arab Emirates
United Arab Emirates: Proportion of bloodstream infection due to Escherichia coli resistant was 51.0% in 2023. ▲ Rising
Latest (2023)
51.0%
Change on year
down 2.7%
World rank
21st
of 58 countries
All-time high
54.1%
in 2020
All-time low
46.1%
in 2019
Years of data
7
2017–2023
Proportion of bloodstream infection due to Escherichia coli resistant in United Arab Emirates, 2017–2023
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of bloodstream infection due to escherichia coli resistant in United Arab Emirates is 51.0%, measured in 2023.
Compared with earlier readings it is down 2.7% on the previous year and up 6.0% over ten years.
United Arab Emirates ranks 21st of 58 countries on this measure, in the middle of the range.
Proportion of bloodstream infection due to Escherichia coli resistant in United Arab Emirates, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 48.1% | — |
| 2018 | 48.4% | +0.7% |
| 2019 | 46.1% | -4.9% |
| 2020 | 54.1% | +17.4% |
| 2021 | 51.7% | -4.5% |
| 2022 | 52.4% | +1.4% |
| 2023 | 51.0% | -2.7% |
United Arab Emirates compared with similar countries
- United Arab Emirates's 51.0% is above the median for high income countries, which is 20.1%, 2.5× the median. (31 countries reporting)
- United Arab Emirates's 51.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 54.7%, 93% of the median. (12 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 47.5% | 46.1% | 48.4% | 3 |
| 2020s | 52.3% | 51.0% | 54.1% | 4 |
Countries ranked near United Arab Emirates
More health data for United Arab Emirates
- Un projection of annual infant deaths, annual growth rate -0.3472 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 2.97 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 308.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 287 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 6.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.0264 units per person (2025)
- Population ages 00-04, male, annual growth rate 3.35 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is proportion of bloodstream infection due to escherichia coli resistant in United Arab Emirates?
- Proportion of bloodstream infection due to escherichia coli resistant in United Arab Emirates was 51.0% in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of bloodstream infection due to escherichia coli resistant recorded in United Arab Emirates?
- The highest recorded value was 54.1% in 2020.
- What is the lowest proportion of bloodstream infection due to escherichia coli resistant recorded in United Arab Emirates?
- The lowest recorded value was 46.1% in 2019.
- How does United Arab Emirates rank for proportion of bloodstream infection due to escherichia coli resistant?
- United Arab Emirates ranks 21st out of 58 countries with data for 2023.
- Is proportion of bloodstream infection due to escherichia coli resistant rising or falling in United Arab Emirates?
- Over the last ten years it is up 6.0%. The long-run trend across the full record is rising.
- Where does this United Arab Emirates data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).